These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25940996)

  • 1. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.
    Swaroop MN; Ferguson CM; Horick NK; Skolny MN; Miller CL; Jammallo LS; Brunelle CL; O'Toole JA; Isakoff SJ; Specht MC; Taghian AG
    Breast Cancer Res Treat; 2015 Jun; 151(2):393-403. PubMed ID: 25940996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
    Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
    Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
    Specht MC; Miller CL; Russell TA; Horick N; Skolny MN; O'Toole JA; Jammallo LS; Niemierko A; Sadek BT; Shenouda MN; Finkelstein DM; Smith BL; Taghian AG
    Breast Cancer Res Treat; 2013 Aug; 140(3):485-94. PubMed ID: 23912961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
    Park S; Lee JE; Yu J; Paik HJ; Ryu JM; Kim I; Bae SY; Lee SK; Kim SW; Nam SJ; Kim EK; Kang E; Yang EJ
    Clin Breast Cancer; 2018 Feb; 18(1):e49-e54. PubMed ID: 28705541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
    Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
    Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
    JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema.
    Zhu W; Li D; Li X; Ren J; Chen W; Gu H; Shu Y; Wang D
    Anticancer Drugs; 2017 Mar; 28(3):350-355. PubMed ID: 27997437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphedema following taxane-based chemotherapy in women with early breast cancer.
    Lee MJ; Beith J; Ward L; Kilbreath S
    Lymphat Res Biol; 2014 Dec; 12(4):282-8. PubMed ID: 25411764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.
    Kilbreath SL; Refshauge KM; Beith JM; Ward LC; Ung OA; Dylke ES; French JR; Yee J; Koelmeyer L; Gaitatzis K
    Breast; 2016 Aug; 28():29-36. PubMed ID: 27183497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living.
    O'Toole JA; Ferguson CM; Swaroop MN; Horick N; Skolny MN; Brunelle CL; Miller CL; Jammallo LS; Specht MC; Taghian AG
    Breast Cancer Res Treat; 2015 Apr; 150(2):381-8. PubMed ID: 25749734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study.
    Miller CL; Colwell AS; Horick N; Skolny MN; Jammallo LS; O'Toole JA; Shenouda MN; Sadek BT; Swaroop MN; Ferguson CM; Smith BL; Specht MC; Taghian AG
    Ann Surg; 2016 Feb; 263(2):399-405. PubMed ID: 25607768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of breast lymphedema and predictors of its development in patients receiving whole breast radiation therapy after breast-conservation surgery.
    Ganju RG; Savvides G; Korentager S; Ward MJ; TenNapel M; Amin A; Wagner J; Mitchell M
    Lymphology; 2019; 52(3):126-133. PubMed ID: 31874124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
    Kim M; Kim SW; Lee SU; Lee NK; Jung SY; Kim TH; Lee ES; Kang HS; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):498-503. PubMed ID: 23541809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of treatment related death and febrile neutropaenia with taxane-based adjuvant chemotherapy for breast cancer in a middle income country outside a clinical trial setting.
    Phua CE; Bustam AZ; Yusof MM; Saad M; Yip CH; Taib NA; Ng CH; Teh YC
    Asian Pac J Cancer Prev; 2012; 13(9):4623-6. PubMed ID: 23167391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
    Rebegea L; Firescu D; Dumitru M; Anghel R
    Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
    Jung SY; Shin KH; Kim M; Chung SH; Lee S; Kang HS; Lee ES; Kwon Y; Lee KS; Park IH; Ro J
    Breast Cancer Res Treat; 2014 Nov; 148(1):91-8. PubMed ID: 25253173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
    Iwamoto T; Hara F; Uemura Y; Mukai H; Watanabe T; Ohashi Y
    Breast Cancer Res Treat; 2020 Jul; 182(2):325-332. PubMed ID: 32462261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.